Krystal Biotech, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
Business Address 2100 WHARTON STREET, PITTSBURGH, PA, 15203
Mailing Address 2100 WHARTON STREET, PITTSBURGH, PA, 15203
Phone (412) 586-5830
Fiscal Year End 1231
EIN 821080209
Financial Overview
FY2025
$1.33B
Total Assets
$522.23M
Stockholders' Equity
$496.30M
Cash & Equivalents
$7.08
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 3 Initial insider ownership report | March 6, 2026 | View on SEC |
| 3 Initial insider ownership report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
Annual Reports
10-K February 17, 2026
- Krystal Biotech achieved a substantial 160% revenue surge to $255 million in 2025, driven by the successful commercial launch of VYJUVEK®.
- The company significantly narrowed its net loss to $115 million, an improvement from $180 million in the prior year.
Insider Trading
STRONG SELL 5 insiders
84 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
SANGAMO THERAPEUTICS, INC
SGMO Biological Products, (No Diagnostic Substances)
Zivo Bioscience, Inc.
ZIVO Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX Biological Products, (No Diagnostic Substances)
EXOZYMES INC.
EXOZ Biological Products, (No Diagnostic Substances)
Aura Biosciences, Inc.
AURA Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.